UC San Diego Health Offers Novel Gene Therapy for Bladder Cancer
July 8, 2024
UC San Diego Health is the first health system in San Diego County to offer novel gene therapy for bladder cancer.
Your search for “Bladder Cancer” returned 32 results
Using Machine Learning Models to Better Predict Bladder Cancer Stages
July 2, 2019
Bladder cancer, one of the most common cancers in the U.S., may be soon helped by a novel non-invasive diagnostic method thanks to machine learning research by researchers at UC San Diego’s San Diego Supercomputer Center and Moores Cancer Center.
New Technology Illuminates Bladder Cancer Detection
March 28, 2023
New UC San Diego Health bladder cancer detection procedure uses blue light and imaging dye to make cancer cells glow pink in clinic and operating room settings.
Mutational Signature Linking Bladder Cancer and Tobacco Smoking Found With New AI Tool
September 26, 2022
UC San Diego researchers have for the first time discovered a pattern of DNA mutations that links bladder cancer to tobacco smoking. The work could help identify what environmental factors, such as exposure to tobacco smoke and UV radiation, cause cancer in certain patients.
New Treatment for Urinary Tract Cancer Could Prevent Kidney Dialysis, Transplant
October 19, 2022
UC San Diego Health is now offering a new treatment for patients with low-grade upper tract urothelial cancer that could safely avoid removal of the entire kidney, which may prevent the need for dialysis or kidney transplant in the future.
UC San Diego Researchers Link Higher Risk of Leukemia to Low Sunlight and Vitamin D
January 6, 2016
Epidemiologists at University of California, San Diego School of Medicine report that persons residing at higher latitudes, with lower sunlight/ultraviolet B (UVB) exposure and greater prevalence of vitamin D deficiency, are at least two times at greater risk of developing leukemia than equatorial populations.
Antibody Drug Conjugates May Help Personalize Radiotherapy for Patients with Cancer
October 4, 2016
Many types of cancer become drug resistant, making them difficult to treat. Researchers with University of California San Diego School of Medicine and Moores Cancer Center have identified a strategy to selectively sensitize certain cancer cells to radiation therapy that may improve tumor control and reduce treatment-related side effects.
Jekyll and Hyde and Seek
February 27, 2018
…of California San Diego School of Medicine and Moores Cancer Center describe how a signaling protein that normally suppresses tumors can be manipulated (or re-programmed) by growth factors, turning it into a driver of malignant growth and metastasis.
Extrachromosomal DNA is common in human cancer and drives poor patient outcomes
August 17, 2020
The multiplication of genes located in extrachromosomal DNA that have the potential to cause cancer drives poor patient outcomes across many cancer types, according to a Nature Genetics study published Aug. 17, 2020 by a team of researchers including the University of California San Diego.
Higher Levels of Vitamin D Correspond to Lower Cancer Risk, Researchers Say
April 6, 2016
Researchers at University of California, San Diego School of Medicine report that higher levels of vitamin D – specifically serum 25-hydroxyvitamin D – are associated with a correspondingly reduced risk of cancer. The findings are published in the April 6, online issue of PLOS ONE.
